{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:52:35Z","timestamp":1791305555830,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG063913"],"award-info":[{"award-number":["AG063913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"DOI":"10.1007\/s40120-026-01047-2","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:04:10Z","timestamp":1791302650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Seizure Occurrence After Mild Cognitive Impairment and Alzheimer\u2019s Disease in Older Adults in the Veterans Affairs Healthcare System: A Retrospective Cohort Study"],"prefix":"10.1007","author":[{"given":"Myriam","family":"Abdennadher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan R.","family":"Berlowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brant","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Abbas","family":"Tahami Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-3295","authenticated-orcid":false,"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1047_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.940515","author":"F Yang","year":"2022","unstructured":"Yang F, Chen L, Yu Y, et al. Alzheimer\u2019s disease and epilepsy: an increasingly recognized comorbidity. Front Aging Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnagi.2022.940515.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"1047_CR2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2174\/1570159x20666220507020635","volume":"20","author":"A Leo","year":"2022","unstructured":"Leo A, Tallarico M, Sciaccaluga M, Citraro R, Costa C. Epilepsy and Alzheimer\u2019s disease: current concepts and treatment perspective on two closely related pathologies. Curr Neuropharmacol. 2022;20(11):2029\u201333. https:\/\/doi.org\/10.2174\/1570159x20666220507020635.","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"1047_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamaneurol.2022.2290","volume":"79","author":"Z Haneef","year":"2022","unstructured":"Haneef Z, Rehman R, Husain AM. Association between standardized mortality ratio and utilization of care in US veterans with drug-resistant epilepsy compared with all US veterans and the US general population. JAMA Neurol. 2022;79(9):879\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2290.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1047_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2022","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2022;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1047_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327. https:\/\/doi.org\/10.1001\/jama.2023.13239.","journal-title":"JAMA"},{"key":"1047_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2019.06.016","volume":"71","author":"J Baker","year":"2019","unstructured":"Baker J, Libretto T, Henley W, Zeman A. The prevalence and clinical features of epileptic seizures in a memory clinic population. Seizure. 2019;71:83\u201392. https:\/\/doi.org\/10.1016\/j.seizure.2019.06.016.","journal-title":"Seizure"},{"issue":"5","key":"1047_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5698\/1535-7511-12.5.184","volume":"12","author":"D Pandis","year":"2012","unstructured":"Pandis D, Scarmeas N. Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr. 2012;12(5):184\u20137. https:\/\/doi.org\/10.5698\/1535-7511-12.5.184.","journal-title":"Epilepsy Curr"},{"issue":"4","key":"1047_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","volume":"16","author":"KA Vossel","year":"2017","unstructured":"Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance. Lancet Neurol. 2017;16(4):311\u201322. https:\/\/doi.org\/10.1016\/S1474-4422(17)30044-3.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1047_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3233\/jad-230613","volume":"94","author":"K Vossel","year":"2023","unstructured":"Vossel K. Putting the brakes on accelerated cognitive decline in Alzheimer\u2019s disease with epileptic activity. J Alzheimers Dis. 2023;94(3):1075\u20137. https:\/\/doi.org\/10.3233\/jad-230613.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1047_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1533317518813551","volume":"34","author":"M Asadollahi","year":"2019","unstructured":"Asadollahi M, Atazadeh M, Noroozian M. Seizure in Alzheimer\u2019s disease: an underestimated phenomenon. Am J Alzheimers Dis Other Demen. 2019;34(2):81\u20138. https:\/\/doi.org\/10.1177\/1533317518813551.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"5","key":"1047_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC, Hauser WA, DelCastillo-Castaneda C, et al. Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia. 2006;47(5):867\u201372. https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00554.x.","journal-title":"Epilepsia"},{"issue":"9","key":"1047_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/wnl.36.9.1226","volume":"36","author":"WA Hauser","year":"1986","unstructured":"Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer\u2019s disease. Neurology. 1986;36(9):1226\u201330. https:\/\/doi.org\/10.1212\/wnl.36.9.1226.","journal-title":"Neurology"},{"issue":"8","key":"1047_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/archneurol.2009.130","volume":"66","author":"N Scarmeas","year":"2009","unstructured":"Scarmeas N, Honig LS, Choi H, et al. Seizures in Alzheimer disease: who, when, and how common? Arch Neurol. 2009;66(8):992\u20137. https:\/\/doi.org\/10.1001\/archneurol.2009.130.","journal-title":"Arch Neurol"},{"issue":"6","key":"1047_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jamaneurol.2025.0552","volume":"82","author":"I Zawar","year":"2025","unstructured":"Zawar I, Quigg M, Johnson EL, Ghosal S, Manning C, Kapur J. Risk factors associated with late-onset epilepsy in dementia and mild cognitive impairment. JAMA Neurol. 2025;82(6):605\u201313. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0552.","journal-title":"JAMA Neurol"},{"issue":"7_supplement","key":"1047_CR15","doi-asserted-by":"publisher","first-page":"P03.134","DOI":"10.1212\/WNL.80.7_supplement.P03.134","volume":"80","author":"J Edwards","year":"2013","unstructured":"Edwards J, Ansari R, Pillai J, Lippa C. Assessing risk factors for developing seizures in patients with Alzheimer\u2019s disease\/mild cognitive impairment (P03.134). Neurology. 2013;80(7_supplement):P03.134-P03. https:\/\/doi.org\/10.1212\/WNL.80.7_supplement.P03.134.","journal-title":"Neurology"},{"issue":"1","key":"1047_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13195-020-00589-3","volume":"12","author":"M Li","year":"2020","unstructured":"Li M, Reisman J, Morris-Eppolito B, Qian SX, Kazis LE, Wolozin B, et al. Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer\u2019s disease after traumatic brain injury. Alzheimers Res Ther. 2020;12(1):33.","journal-title":"Alzheimers Res Ther"},{"key":"1047_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/brainsci15050434","volume":"15","author":"M Li","year":"2025","unstructured":"Li M, Wang Y, Kazis L, Xia W. Hypertension a predictive risk factor on progression to Alzheimer\u2019s disease using APOE\u03b54 as a benchmark. Brain Sci. 2025;15:434.","journal-title":"Brain Sci"},{"key":"1047_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14283\/jarlife.2023.8","volume":"12","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li M, Kazis L, Xia W. The comparative effectiveness of monotherapy and combination therapies: impact of angiotensin receptor blockers on the onset of Alzheimer\u2019s disease. J Aging Res Lifestyle. 2023;12:35.","journal-title":"J Aging Res Lifestyle"},{"issue":"6","key":"1047_CR19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s40120-023-00540-2","volume":"12","author":"BJ Aguilar","year":"2023","unstructured":"Aguilar BJ, Miller D, Jasuja G, et al. Rule-based identification of individuals with mild cognitive impairment or Alzheimer\u2019s disease using clinical notes from the United States Veterans Affairs Healthcare System. Neurol Ther. 2023;12(6):2067\u201378. https:\/\/doi.org\/10.1007\/s40120-023-00540-2.","journal-title":"Neurol Ther"},{"issue":"2","key":"1047_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/jad-230850","volume":"97","author":"P Morin","year":"2024","unstructured":"Morin P, Aguilar BJ, Li X, et al. Alzheimer\u2019s disease stage transitions among United States veterans. J Alzheimers Dis. 2024;97(2):687\u201395. https:\/\/doi.org\/10.3233\/jad-230850.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1047_CR21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2018.1935","volume":"75","author":"EL Johnson","year":"2018","unstructured":"Johnson EL, Krauss GL, Lee AK, et al. Association between midlife risk factors and late-onset epilepsy: results from the Atherosclerosis Risk in Communities Study. JAMA Neurol. 2018;75(11):1375\u201382. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1935.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1047_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/appi.neuropsych.15060143","volume":"28","author":"RA Sarkis","year":"2016","unstructured":"Sarkis RA, Dickerson BC, Cole AJ, Chemali ZN. Clinical and neurophysiologic characteristics of unprovoked seizures in patients diagnosed with dementia. J Neuropsychiatry Clin Neurosci. 2016;28(1):56\u201361. https:\/\/doi.org\/10.1176\/appi.neuropsych.15060143.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1047_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(25)00425-9","author":"K Vossel","year":"2026","unstructured":"Vossel K, Johnson EL, Cretin B, Matsumoto R. Epileptic activity in Alzheimer\u2019s disease: emerging insights and therapeutic implications. Lancet Neurol. 2026. https:\/\/doi.org\/10.1016\/s1474-4422(25)00425-9.","journal-title":"Lancet Neurol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01047-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01047-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01047-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:04:12Z","timestamp":1791302652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-01047-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":23,"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01047-2","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Amir Abbas Tahami Monfared is and Quanwu Zhang was employees of Eisai Inc. The other authors (Myriam Abdennadher, Ying Wang, Joel Reisman, Wen Hu, Peter Morin, Dan R Berlowitz, Brant Mittler, and Weiming Xia) declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The VA Bedford Healthcare System Institutional Review Board approved this study (E23-85). Informed consent was waived and is not applicable as data were all fully de-identified before access.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}